Research Use Only
HAUZ Research supplies compounds strictly for in-vitro laboratory use. Please confirm each statement before entering the site.
By entering, you agree to our Terms of Service.
Leave siteLilly’s newly announced 80-week TRIUMPH-2 findings add a pivotal clinical-data update to retatrutide research, while the compound remains investigational and detailed results await scientific presentation.
The research peptide market has undergone a significant consolidation in 2025–2026. The closure of Peptide Sciences, FDA enforcement actions against multiple vendors, and new regulatory scrutiny have reduced the number of active suppliers while raising the bar for quality documentation and compliance.
Tesamorelin is a synthetic 44-amino acid peptide analogue of endogenous growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoic acid group at the N-terminus to increase stability. It is the only GHRH analogue to have received FDA approval for a specific indication, making it a well-characterized research tool for studying the GH/IGF-1 axis.
AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide corresponding to amino acids 176-191 of human growth hormone (hGH), with an additional tyrosine residue at the N-terminus. It was developed as a research tool to study the lipolytic activity of hGH independently of its growth-promoting and insulin-sensitizing effects.
News & Updates
Your cart is currently empty!
News & Updates
Subscribe to the latest updates and news.
Notifications